Skip to main content
. 2022 Aug 25;37(2):871–880. doi: 10.1007/s00464-022-09459-5

Table 4.

The comparisons of clinicopathological characteristics between ER + SR and ER-alone treatments in extremely low-risk group with VM(−), LVI(−), and PD(−)

ER + SR ER-alone p_value
2 test)
(n = 21) (n = 63)
Age
Median [IQR] 60.00 [55.00, 65.00] 63.00 [57.50, 67.00] 0.382#
Sex
Female 4 (19.0%) 15 (23.8%) 0.770^
Male 17 (81.0%) 48 (76.2%)
SMI ≥ 200 μm
Negative 5 (23.8%) 14 (22.2%) 1.000
Positive 16 (76.2%) 49 (77.8%)
Location
Upper 6 (28.6%) 10 (15.9%) 0.437
Middle 7 (33.3%) 24 (38.1%)
Lower 8 (38.1%) 29 (46.0%)
Concurrent LNM
Negative 21 (100%) NA NA
Positive 0 (0%) NA
Post-resection LNM
Negative 21 (100.0%) 61 (96.8%) 1.000^
Positive 0 (0.0%) 2 (3.2%)
Overall LNM
Negative 21 (100.0%) 61 (96.8%) 1.000^
Positive 0 (0.0%) 2 (3.2%)
Post-resection DOM
Negative 20 (95.2%) 61 (96.8%) 1.000^
Positive 1 (4.8%) 2 (3.2%)

IQR interquartile range; PD poor differentiation; LVI lymphovascular invasion; VM vertical margin; SMI Submucosal invasion; LNM lymph node metastasis; DOM distant organ metastasis; NA not available

#Mann–Whitney test

^Fisher’s exact test